ID: ALA86740

Max Phase: Preclinical

Molecular Formula: C7H9N5S

Molecular Weight: 195.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)/N=C(\S)Nc1ccccn1

Standard InChI:  InChI=1S/C7H9N5S/c8-6(9)12-7(13)11-5-3-1-2-4-10-5/h1-4H,(H5,8,9,10,11,12,13)

Standard InChI Key:  AHBUIBGELQDDKY-UHFFFAOYSA-N

Associated Targets(non-human)

Glucose-6-phosphatase 38 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 195.25Molecular Weight (Monoisotopic): 195.0579AlogP: 0.67#Rotatable Bonds: 1
Polar Surface Area: 87.15Molecular Species: ZWITTERIONHBA: 2HBD: 4
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.35CX Basic pKa: 15.00CX LogP: 1.57CX LogD: 1.57
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.30Np Likeness Score: -1.31

References

1. Farhanullah, Sil D, Tripathi BK, Srivastava AK, Ram VJ..  (2004)  Synthesis and glucose-6-phosphatase inhibitory activity of (thiouriedo)alkanoic acid esters.,  14  (10): [PMID:15109654] [10.1016/j.bmcl.2004.02.079]

Source